188 related articles for article (PubMed ID: 7526835)
21. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
22. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1994; 15():391-412. PubMed ID: 7779590
[No Abstract] [Full Text] [Related]
23. Prolonged administration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) after T-cell-depleted allogeneic bone marrow transplantation.
De Witte T; Vreugdenhil G; Schattenberg A
Transplant Proc; 1993 Aug; 25(4 Suppl 3):57-60. PubMed ID: 8351721
[No Abstract] [Full Text] [Related]
24. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
26. Autologous bone marrow transplantation in chronic myeloid leukaemia.
Divya
Natl Med J India; 1998; 11(1):19-21. PubMed ID: 9557515
[No Abstract] [Full Text] [Related]
27. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia.
Mavroudis DA; Read EJ; Molldrem J; Raptis A; Plante M; Carter CS; Phang S; Dunbar CE; Barrett AJ
Bone Marrow Transplant; 1998 Mar; 21(5):431-40. PubMed ID: 9535034
[TBL] [Abstract][Full Text] [Related]
28. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
[TBL] [Abstract][Full Text] [Related]
29. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1990; 11():321-42. PubMed ID: 2223398
[No Abstract] [Full Text] [Related]
30. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.
Baker KS; Loberiza FR; Yu H; Cairo MS; Bolwell BJ; Bujan-Boza WA; Camitta BM; Garcia JJ; Ho WG; Liesveld JL; Maharaj D; Marks DI; Schultz KR; Wiernik P; Zander AR; Horowitz MM; Keating A; Weisdorf DJ
J Clin Oncol; 2005 Oct; 23(28):7032-42. PubMed ID: 16145067
[TBL] [Abstract][Full Text] [Related]
31. Biannual report of the Cochrane Haematological Malignancies Group.
Trelle S; Higgins G; Kober T; Engert A
J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
[No Abstract] [Full Text] [Related]
32. Twenty years of bone marrow transplantation in Essen - 1995 update.
Runde V; Beelen W; Schaefer UW
Clin Transpl; 1995; ():311-4. PubMed ID: 8794276
[TBL] [Abstract][Full Text] [Related]
33. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1992; 13():327-48. PubMed ID: 1389914
[No Abstract] [Full Text] [Related]
34. [The role of bone marrow transplantation in the treatment of leukemia].
Robak T
Przegl Lek; 1990; 47(10):723-7. PubMed ID: 2089452
[No Abstract] [Full Text] [Related]
35. Allogeneic family-unrelated bone marrow transplantation in acute and chronic myeloid leukemia.
Fauser AA; Köchling G; Digel W; Finke J; Thiel M; Heinz J; Bross KJ; Dölken G; Mertelsmann R
Bone Marrow Transplant; 1993; 11 Suppl 1():83. PubMed ID: 8448558
[No Abstract] [Full Text] [Related]
36. Leukaemias into the 21st century. Part 2: the chronic leukaemias.
Gibson J; Iland HJ; Larsen SR; Brown CM; Joshua DE
Intern Med J; 2013 May; 43(5):484-94. PubMed ID: 23668266
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy of estrogen-progestin replacement therapy after bone marrow transplantation].
Bellati U; Iammarrone E; Bavaro P; Mattaeis RD; Bizzarri M; Carabella G; Torlontano G
Minerva Ginecol; 1996 Sep; 48(9):351-4. PubMed ID: 8999381
[TBL] [Abstract][Full Text] [Related]
38. Risk assessment in haematopoietic stem cell transplantation.
Gratwohl A
Best Pract Res Clin Haematol; 2007 Jun; 20(2):119-24. PubMed ID: 17448952
[No Abstract] [Full Text] [Related]
39. Twenty-five Zambians with leukaemias.
Fleming AF
East Afr Med J; 1989 Mar; 66(3):162-6. PubMed ID: 2591324
[TBL] [Abstract][Full Text] [Related]
40. Applications and indications for bone marrow transplantation in adults.
Weinberger BB
J La State Med Soc; 1994 Mar; 146(3):94-100. PubMed ID: 7964116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]